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SIR BENJAMIN COLLINS BRODIE (1783–1862) – A PIONEER
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Aim: Benjamin Brodie was a London surgeon who investigated joint disease
by observation and morbid anatomy for over thirty years in the first half of
the 19th century. He summarised his rheumatology experience in his book
‘Pathological and Surgical Observations on the Diseases of Joints’. Others
have briefly mentioned his contributions, but to date no detailed analysis
has been done.
Methods:The authors used the first (1818), third (1834) and fifth (1850)
editions of Brodie’s book to give a more comprehensive picture of his
achievements.
Results: The descriptions of disease given before about 1850 are often
unintelligible now, yet Brodie’s are admirably clear. He describes reactive
arthritis in the first edition of his book more completely than authors before
him, or even Reiter a century later. He recognised that the conjunctivo-
urethral-synovial syndrome can occur independently of gonorrhoea, that
there are often repeated attacks, and that irits is a complication – the first
indication that this syndrome is part of what we now call seronegative
spondyloarthritis. Brodie showed that there were causes of joint inflamma-
tion other than tuberculosis or pyogenic infection, and was proud of having
saved many limbs that would otherwise have been amputated.
The fifth edition (1850) has among the earliest descriptions in English of
ankylosing spondylitis and rheumatoid arthritis.
Conclusions: Brodie was showered with honours (Fellowship of the Royal
Society, Presidency of the Royal College of Surgeons, a Baronetcy) and had
a very lucrative private practice, but none of this detracted from his work
and his clinical teaching at St. George’s Hospital. His appreciation of
rheumatic disease demands him to be widely recognised as a pioneer
rheumatologist.
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Aim:To describe clinical and histopathological features of statin associated
necrotizing autoimmune myopathies (NAM) in Indigenous Australians and
increase awareness of this condition amongst treating physicians.
Methods: Cases were collected through the Rheumatology Department at
The Townsville Hospital between March 2012 and January 2015. A chart
review was performed to obtain retrospective information about each case.
We detail patient demographics, presenting features, histopathological find-
ings, autoimmune profile, treatment and outcomes.
Results: 4 Indigenous Australians were identified as having a biopsy con-
firmed statin associated NAM. All patients had been on atorvastatin for at
least 2 years and had significant proximal weakness with average CK level
on presentation 16,820 U/L. Predisposing factors for myopathy included
vitamin D deficiency and diabetes mellitus (all cases), with primary hypo-
thyroidism and liver cirrhosis identified in two other cases.Two individuals
were positive for the auto-antibody anti-HMGCR. Histopathological find-
ings included muscle necrosis with varying degrees of inflammation, mem-
brane attack complex (MAC) deposition andMHC-1 upregulation.Treatment
involved various combinations of prednisolone, IVIG, methotrexate and
mycophenolate. Recovery was slow but favourable in all cases with an
average length of inpatient stay of 54 days.There was a significant delay in
diagnosis of 1–3 months in two of the cases.
Conclusions: The statin associated necrotizing autoimmune myopathies
are rare but important disorders that cause significant morbidity to affected
individuals. Given the prevalence of cardiovascular disease in Indigenous
Australians, further research is required to facilitate earlier diagnosis and
improved treatment outcomes.
ARP38
EPIDEMIOLOGY OF ANCA-ASSOCIATED VASCULITIS IN
TOWNSVILLE, NORTH QUEENSLAND
Gray J1, Soden M2
1Queensland Health
2Townsville Hospital, Queensland Health, Queensland
Aim:The primary aim of the study was to obtain the prevalence of ANCA-
associated vasculitis (AAV) inTownsville. A secondary aim was to compare
this study with other centres with different latitudes in Australia and New
Zealand. A latitudinal variance in disease rates for ANCA-associated vas-
culitis has been shown in Europe and New Zealand.
Methods:The pathology database at Townsville Hospital was respectively
searched for all positive ANCA tests between 2009 and 2013. Patient files
were reviewed for all positive results to determine whether they met the
ACR criteria for granulomatosis with polyangiitis (GPA) or Chapel Hill
criteria for microscopic polyangiitis (MPA) or eosinophilic granulomatosis
with polyangiitis (EGPA).
Results: 5013 ANCA tests were requested at Townsville Hospital in the 5
year study period. 61 patients had positive ANCA results. 23 patients met
criteria for ANCA-associated vasculitis with 13 cases of MPA, 6 cases of
GPA, 2 cases of EGPA and 2 others. 14 out of those 23 patients lived in the
Townsville Health District. Townsville Health District had a population of
230,000 in 2010 giving a prevalence of 61 cases of AAV/million population
over 5 years. MPA had a rate of 34/million and GPA 22/million.
Conclusions: This study shows lower rates of AAV than other southern
hemisphere studies in Christchurch (151/million/5 years) or Australian
Capital Territory (148/million/5 years). These results add further evidence
to the observed latitudinal difference in disease.The study may have under-
estimated the disease burden due to a number of factors. Firstly, it did not
include a local private hospital and secondly, it did not include cases that
had ANCA tests performed at private laboratories or before the study
began.
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Aim: The aim of this study was to review and compare the clinical,
pathological and ultrastructural features of patients with biopsy proven
idiopathic inflammatory myositis (IIM) and necrotising myopathy (NM)
exposed to statin with those who were statin naive.
Methods: All muscle biopsies (myositis and non-myositis) performed in
South Australia between January 2012 and August 2013 inclusive were
reviewed with respect to statin exposure. One author blinded to biopsy
results, collected data related to statin exposure using standarised biopsy
forms and obtained missing data by checking medical records and contact-
ing health providers. Patients were classified on the basis of histological
criteria and routine electron microscopy was performed on all specimens.
Results: IIM and NM comprised 78/186 of biopsies i.e. 42% of all cases
reviewed. (17/78 PM, 16/78 IBM, 10/78 DM, 21/78 MNOS and 14/78
NM) 41/78 (53%) were exposed to statin in this group. ‘Non-myositis’
control cases comprised 108/186 and 21/108 (19.4%) had been exposed to
statin. In 9/78 ‘myositis’ biopsies distinctive electron dense granules (0.2–
0.5 μΜm) within single membrane bound vacuoles were noted (type 2
autophagic vacuoles).
Conclusions:We report a distinctive ultrastructural abnormality with fea-
tures of a late autophagic vacuole observed in 9/41 cases of immunemediated
myopathies. All of these patients were exposed to statins.We speculate that
the statin induced changes in cholesterol metabolism of cell membranes in
some way interferes with the multistep process of autophagy in the setting of
muscle fibre necrosis/regeneration and inflammation.TheLMobservation of
vacuolar changes in otherwise normal fibres in all 9 cases showing AV-2s
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